NCT06610188View on ClinicalTrials.gov

The Effect of Inulin in Irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

December 3, 2021

Study Completion Date

April 1, 2023

Conditions
Bowel SymptomsDepression DisordersInulinConstipationQuality of Life (QOL)Irritable Bowel Syndrome (IBS)
Interventions
DIETARY_SUPPLEMENT

Prebiotic group

products containing a total of 9.2 g (4.6 g twice a day) inulin/oligofructose (50/50) mixture (prebiotic group) that individuals should consume daily were delivered to individuals in identical opaque bags.

DIETARY_SUPPLEMENT

Maltodextrin (Placebo)

products containing a total of 9.2 g (4.6 g twice a day) maltodextrin (placebo group) that individuals should consume daily were delivered to individuals in identical opaque bags.

Trial Locations (1)

47200

Mardin Artuklu University, Mardin

All Listed Sponsors
lead

Mardin Artuklu University

OTHER

NCT06610188 - The Effect of Inulin in Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter